Lipidomics, a branch of metabolomics, is the large-scale study of pathways and networks of all cellular lipids in biological systems such as cells, tissues or organisms. The recent advance in mass spectrometry technologies have enabled more comprehensive lipid profiling in the biological samples. In this review, we compared four representative lipid profiling technoligies including GC-MS, LC-MS, direct infusion-MS and imaging-MS. We also summarized representative lipid database, and further discussed the applications of lipidomics to the diagnostics of various diseases such as diabetes, obesity, hypertension, and Alzheimer diseases.
INTRODUCTION
Lipids are broadly defined as fat-soluble molecules that include a wide range of molecular structures [1] . Lipids exhibit a wide variety of cellular functions such as cellular structural support, energy storage, protein trafficking, maintenance of electrochemical gradients, and cell signaling.
They also play a vital role in Alzheimer's disease [2, 3] , cardiovascular diseases [4, 5] , inflammation [6] , and metabolic diseases such as diabetes [7, 8] , hyperlipidemia [9] , hypertension [10, 11] , and obesity [12, 13] . Lipidomics, a branch of metabolomics, is the large-scale study of pathways and networks of cellular lipids in biological systems such as cells, tissues, or organisms [14] . Lipidomics can also be defined as "the full characterization of lipid molecules and their biological functions with respect to expression of proteins involved in lipid metabolism and function, including gene regulation" [15] . The field covers the quantitative and qualitative determination of lipids in time and space, the study of lipid transporters and lipid-metabolizing enzymes, and lipid-lipid and lipid-protein interactions [16, 17] Methyl siloxane - [118] Cholesterol ester Serum 20 μL SPE MSTFA/NH4I/DTE (500:4:2)
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LIPIDOME PROFILING
In the field of metabolite research, nuclear magnetic resonance (NMR) and mass spectrometry (MS) are frequently used in metabolite profiling. NMR has advantages in analytic reproducibility but has low sensitivity, making it unsuitable for analysis of small sample concentrations, such as those involved lipid metabolite analysis. Thus, analytic equipment based on MS is most commonly used in lipidomics research. Based on the method of sample introduction, MS is classified as gas chromatography (GC)-MS, liquid chromatography (LC)-MS, or direct infusion-MS, with each method having its own advantages.
GC-MS-based lipid profiling
GC-MS is best for the analysis of lipids such as free fatty acids (FFAs) and steroids. Generally, FFAs and steroids are analyzed by transforming the compounds into volatile esters via silylation derivatization ( Table 1) . The most prominently used derivatization reagent for silylation is N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA), while ammonium iodide (NH4I), dithioerythritol (DTE), trimethylchlorosilane (TMCS), trimethyliodosilane, or trimethylsilylimidazole (TMSIm) are often added to accelerate the process [18] . FFA and steroid analyses often require methylsiloxane or 5% diphenylpolysiloxane columns. High temperature-compatible columns like a silicosteel-treated stainless steel capillary column (MXT-1) are used when increasing the GC oven temperature for the analysis of low volatile compounds like fatty acid esters of steroids and cholesterol esters [19] .
LC-MS-based lipid profiling
For the analysis of phospholipids, neutral lipids, and sphingolipids, which are greater in molecular weight and less volatile than FFAs and steroids, LC-MS is mainly used.
Lipid profiling via LC-MS is more advantageous than GC-MS in that it does not require a derivatization reaction.
Generally, reverse phase columns like C8/C18 or hydrophilic interaction liquid chromatography (HILIC) columns are used for lipid analysis (Table 2) . To increase the separation of lipids, modifiers can be added to the mobile phase, including ethylamine [20] , formic acid [21, 22] , ammonium acetate [23, 24] , and ammonium formate [25] [26] [27] . Bang et al. [26] compared the phospholipid analysis sensitivity of different types of mobile phase additives (ammonium hydroxide, ammonium acetate, and ammonium formate) and reported that a modifier containing a mixture of 0.05% ammonium hydroxide and 1 mM ammonium formate (pH 9.3) yielded the greatest improvement in analytical sensitivity. In addition, MS-selected reaction monitoring (SRM) [28] [29] [30] [31] is used for the quantitative analysis of lipids, while precursor ion scanning or neutral loss scanning is used for type-specific selective lipid profiling [32] [33] [34] [35] . Recently, Bollinger et al. [21] derived N-(4-aminomethylphenyl)pyridinium (AMPP) from a fatty acid and analyzed it via LC-MS in SRM mode, reporting a 60,000-fold increase in analytical sensitivity compared with underivatized fatty acids.
Direct infusion-MS-based lipid profiling
In 1994, Han et al. [36] directly injected a sample for lipid profiling into a mass spectrometer, avoiding the negative effects of chromatography, increasing the signal to noise ratio, and establishing what is now known as the direct infusion-MS method. Unlike GC-MS and LC-MS, which utilize columns to separate compounds, direct infusion-MS has the advantage of a shortened analysis time but is disadvantageous in that lipid compounds with the same m/z will not separate. To address this issue, MS with high resolution or detection methods specific for certain lipid types (e.g., neutral loss scanning or precursor ion scanning) are used in direct infusion-MS (Table 3 ) [37] [38] [39] [40] [41] [42] [43] . To detect trace amounts of lipids in samples, Wang et al. [44] and Han et al. [34] produced and analyzed derivatives by reacting DG with N,N-dimethylglycine (DMG) [44] and PE with [48] fluorenylmethyloxycarbonyl chloride [34] . Modifiers such as LiOH, LiCl, and ammonium acetate are also often added to improve the formation of adduct ions [44] [45] [46] .
Imaging MS-based lipid profiling
Recently, there has been a significant increase in the identification of biomarkers related to disease through analysis of lipid metabolites present in tissues via imaging MS.
The matrix-assisted laser desorption/ionization technique is mainly used in imaging MS to ionize lipid metabolites within samples. Ionization efficiency is increased for specific lipid classes by changing the solvent concentrations or modifier compositions in the matrix added to the samples. The most highly used matrices for lipid profiling by imaging MS include 9-aminoacriaine [47] , α-cyano-4-hydroxycinnamic acid (CHCA) [47] , 2,6-dihydroxyacetophenone (DHA) [48] [49] [50] , 2,5-dihydroxybenzoic acid (DHB) [48, 51] , and 2-mercaptobenzothiazole (MBT) ( Table 4 ) [52] . Piperidine [63] . The great advantage of this DB is that the data can be used without compatibility issues due to MS equipment types; in addition, LipidBlast has the largest amount of MS/MS spectrum data, representing up to 212,516 lipid metabolites.
Additional lipid MS databases
Other lipidome DBs that are helpful in the identification of lipids found in biological samples include ALEX [64] , Cyberlipid [65] , LipidAT [66] , Lipid Data Analyzer [67] , LipidHome [68] , LipidQA [69] , LipidXplorer [70] and MZmine (Table 7 ) [71] .
APPLICATIONS OF LIPIDOMICS IN DISEASE RESEARCH

Applications in metabolic disease
Metabolic disease arises from the failure of individual organs to properly execute metabolism, creating an imbalance in carbohydrates, lipids, proteins, vitamins, minerals, and water. The most well-known of such metabolic diseases are diabetes, obesity, hypertension. Currently, research in early detection methods and treatment response is being actively conducted (Table 8) .
Neutral lipids and phospholipids have been reported as lipid metabolite markers related to diabetes. Generally, the neutral lipids TG [72] [73] [74] and CE [72] are notably higher in the plasma of diabetic patients than that of normal patients. From the decreased levels of TG and CE in the plasma of diabetic mice treated with oral rosiglitazone [75] , increased neutral lipids is a shared phenomenon in both humans and animals suffering from diabetes. According to recently released data from Rhee [8] This experiment is concurrent with the report of Huo et al. [76] in that diabetic patients treated with metformin had reduced plasma LPC 16:0, LPC 18:0, and LPC 18:2 levels.
However, a decrease in PC (PC 16:0/18:0 and PC 18:0/20:4) with increased LPC was confirmed, while some PC types (PC 16:0/18:2) showed increased levels [74] , indicating the need for further confirmatory studies. Rhee et al. reported recently that risk of type II diabetes increased when PC (PC34:2 and PC36:2) with low levels of unsaturation increased, while PC (PC38:6 and LPC22:6) with high levels of unsaturation decreased [8] . For other phospholipids, plasma PE increased [74, 77] while PI decreased compared to the levels in healthy patients [74] .
As in diabetes, neutral lipids and phospholipids are also used as lipid metabolite markers in obesity. TG [12, [78] [79] [80] , a neutral lipid, was shown to increase in obese patients compared to healthy patients and demonstrated a correlative decrease with decrease in patient weight [81] . DG [12, 78] , as well as TG, was significantly increased in obese patient plasma. The phospholipids PC [82] , PE [13, 78] , and PI [13] were increased in obese patients, while PC decreased to the normal value with a decrease in patient weight [81] . LPC, on the other hand, differed with acyl chain type, showing an increase with LPC 18:0 [79, 80, 82] but a decrease with LPC 18:1 or LPC 18:2 [79, 82] . These discrepant results in- dicate the need for further research in order to better understand the roles of these lipids in obesity. SM, a type of sphingolipid, decreased [12] in obese patients, while plasma SM level increased with patient weight loss [81] .
Lipidome markers related to hypertension include neutral lipids, sphingolipids, and phospholipids. TG was significantly increased in hypertensive patients compared to that of healthy patients [10, 78] but decreased after treatment with anti-hypertensive medication [10] . Some DGs (DG 16:0/22:5 and DG 16:0/22:6) showed significantly higher levels in hypertensive patients plasma compared to that in normal patients [83] . LPC(22:6, 20:4, 18:1), PC(40:6), and SM(16:1, 24:2) were elevated in hypertensive patients compared to the levels in healthy patients, and they decreased after treatment with an herbal medicine (Ping Gan) with anti-hypertensive characteristics [10, 11] . Ceramide increased in hypertensive animal models as well as in hypertensive human patients [84] .
Applications in dermatological disease
In dermatological diseases like psoriasis and atopic dermatitis, lipid metabolites are being actively studied (Table 9 ).
Ceramide (CER), a sphingolipid, is recognized as the most important lipid metabolite in dermatological disease, accounting for nearly 40% of the stratum corneum, the outermost part of the skin layer [85, 86] . FFAs, neutral lipids, and cholesterol are also known to be present in the skin. The total ceramide content is decreased in atopic dermatitis patients compared to healthy patients [87] [88] [89] . In observing different types of ceramides, the total contents of non-hy- were decreased in atopic dermatitis patients compared to those in the healthy group, while ceramides with less than 40 carbons were increased [87] . Thus, additional research should be done on the differences in sphingoid and acyl chain numbers and types of ceramides with respect to dermatologic diseases. As with atopic dermatitis, psoriasis patients indicated a decrease in ceramide content within patient skin [91] . Recent reports have indicated improvements in dermatitis after treatment with ceramide and ceramide-like analogues [92] [93] [94] , suggesting that research on ceramide function and importance within dermatological diseases should continue.
Applications in neurological disease
Lipids are important moderators of brain functions and are strongly related to neurological diseases like Alzheimer's disease (AD). Currently, the research focus of lipidome markers in neurological disease is indeed for those involved in AD and the related lipid metabolite markers include neutral lipids, sphingolipids, and phospholipids (Table 10 ). DG increase and sphingomyelinase activation-mediated increase in ceramide due to the hydrolysis of β-amyloid peptide (A β)-stimulated PIP2 were observed in the prefrontal cortex of AD patients, while PE and LPC were decreased [95] . A decrease in PE in an Alzheimer's model mouse brain has also been reported [96] . CE, amyloidogenesis-related SM, and ganglioside GM3 increased in the entorhinal cortex, indicating tissue specificity in regard to lipid content changes in AD [95] . For sphingolipids, the brain SM content in the AD model mouse [95] and AD patients [95] , especially those SM species with medium chain fatty acids (C16-C20), decreased as a result of the increase in SM degradation due to Aβ42-mediated sphingomyelinase activation [97, 98] .
Meanwhile, a hydroxylated fatty acid-containing galactosylceramide (GalCer) was increased in the AD brain due to an increase in fatty acid hydroxylase activation [28] . In the forebrain of AD model mice, similar to that of the human entorhinal cortex, CE and ganglioside GM3 contents increased, while the phospholipids PG, PS, PI, and LPE decreased [95] . GM3 recovered to the normal range once the PLD2 gene of AD model mice was removed [95] , which indicated that GM3 can be used as an AD-related biomarker.
CE also increased significantly in mutant human amyloid precursor protein (APP)-expressing mouse brain, which is indicative of CE use as an AD biomarker [96] . The CE mechanism of AD is related to functions in acyl-coenzyme A:cholesterol acyltransferase (ACAT), which converts cholesterol to CE. Thus, ACAT participates in Aβ peptide production, and an ACAT inhibitor decreases the production and accumulation of Aβ [99] . also participated in PC accumulation [101] . Such increases in PC were recovered to normal values by treatment with epigallocatechin gallate, a key compound in green tea polyphenols, indicating that PC can be used as a biomarker for Aβ-induced neurotoxicity [100] . Among the multiple isozymes for the PLA2 enzyme, some, including cPLA2, were activated by Aβ peptide, significantly decreasing specific PCs (PC36:5, PC38:6, and PC40:6) in AD patient plasma [102] . The LPC/PC ratio in AD patient cerebrospinal fluid was decreased with statistical significance [16] . Collectively, these results demonstrate that anomalies in the cell membrane metabolism of phospholipids mediated by Aβ peptide-induced PLA2 affect membrane fluidity, leading to participation in platelet formation, and ultimately to AD [103] [104] [105] [106] . When the Aβ peptide level increased, the reactive oxygen species that oxidize plasmalogen PE (pPE) increased in production, and the pPE level decreased. Thus, pPE38:2 and similar pPEs were greatly decreased in APP/tau mice [96] and AD patient brains [2] . Aβ is known to destabilize alkyldihydroxyacetonephosphate synthase, a plasmalogen-synthesizing enzyme [107] .
For the neutral lipids, the characteristics were different with respect to the fatty acid types present in the acyl chains. Levels of TG56:7 and TG 60:12 containing docosahexaenoic acid (DHEA) increased in the AD patient entorhinal cortex as well as in the brain tissue of ten-month-old APP/tau mice [95, 96] . TG62:14, TG62:13, TG60:13, TG60:11, and TG58:10 containing DHEA significantly increased in the plasma of ten-month-old AD mice [96] . DHEA-conjugated CE increased in APP/tau mice brains, indicating that DHEA accumulates in the AD patient brain in the form of TG and CE. Unlike DHEA, TG54:4
and TG58:7 containing arachidonic acid decreased in the AD patient prefrontal cortex and AD mice brain [95, 96] .
PERSPECTIVE AND FUTURE OF LIPIDOMICS
Lipidomics, a branch of metabolomic research, is a rela- 
